- Home
- VTEX vs BBOT Comparison
VTEX vs BBOT Comparison
Compare VTEX & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTEX
- BBOT
- Stock Information
- Founded
- VTEX 1999
- BBOT 2016
- Country
- VTEX Cayman Islands
- BBOT United States
- Employees
- VTEX N/A
- BBOT N/A
- Industry
- VTEX Computer Software: Prepackaged Software
- BBOT Biotechnology: Pharmaceutical Preparations
- Sector
- VTEX Technology
- BBOT Health Care
- Exchange
- VTEX Nasdaq
- BBOT Nasdaq
- Market Cap
- VTEX 742.4M
- BBOT 822.9M
- IPO Year
- VTEX 2021
- BBOT N/A
- Fundamental
- Price
- VTEX $4.41
- BBOT $12.36
- Analyst Decision
- VTEX Strong Buy
- BBOT Strong Buy
- Analyst Count
- VTEX 4
- BBOT 4
- Target Price
- VTEX $7.63
- BBOT $25.00
- AVG Volume (30 Days)
- VTEX 1.1M
- BBOT 401.3K
- Earning Date
- VTEX 11-04-2025
- BBOT 01-01-0001
- Dividend Yield
- VTEX N/A
- BBOT N/A
- EPS Growth
- VTEX 48.79
- BBOT N/A
- EPS
- VTEX 0.05
- BBOT N/A
- Revenue
- VTEX $230,497,000.00
- BBOT N/A
- Revenue This Year
- VTEX $10.08
- BBOT N/A
- Revenue Next Year
- VTEX $14.18
- BBOT N/A
- P/E Ratio
- VTEX $84.58
- BBOT N/A
- Revenue Growth
- VTEX 4.53
- BBOT N/A
- 52 Week Low
- VTEX $3.92
- BBOT $8.70
- 52 Week High
- VTEX $7.56
- BBOT $13.05
- Technical
- Relative Strength Index (RSI)
- VTEX 49.73
- BBOT N/A
- Support Level
- VTEX $4.27
- BBOT N/A
- Resistance Level
- VTEX $4.52
- BBOT N/A
- Average True Range (ATR)
- VTEX 0.15
- BBOT 0.00
- MACD
- VTEX 0.03
- BBOT 0.00
- Stochastic Oscillator
- VTEX 43.97
- BBOT 0.00
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
About BBOT BridgeBio Oncology Therapeutics Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.